These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28667915)

  • 1. Knockdown of TNF receptor-associated factor 2 (TRAF2) modulates in vitro growth of TRAIL-treated prostate cancer cells.
    Wei B; Ruan J; Mi Y; Hu J; Zhang J; Wang Z; Hu Q; Jiang H; Ding Q
    Biomed Pharmacother; 2017 Sep; 93():462-469. PubMed ID: 28667915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.
    Wei B; Liang J; Hu J; Mi Y; Ruan J; Zhang J; Wang Z; Hu Q; Jiang H; Ding Q
    Med Sci Monit; 2017 Aug; 23():4192-4204. PubMed ID: 28855498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.
    Liang J; Zhang J; Ruan J; Mi Y; Hu Q; Wang Z; Wei B
    Med Sci Monit; 2017 Nov; 23():5504-5514. PubMed ID: 29151113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Zhang X; Li W; Olumi AF
    Clin Cancer Res; 2007 Dec; 13(23):7181-90. PubMed ID: 18056199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
    Yoo J; Park SS; Lee YJ
    J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis.
    Griffith TS; Kemp TJ
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):175-84. PubMed ID: 12811515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer.
    Arafat W; Zhou T; Naoum GE; Buchsbaum DJ
    J Egypt Natl Canc Inst; 2015 Dec; 27(4):205-15. PubMed ID: 26385392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.
    Shankar S; Siddiqui I; Srivastava RK
    Mol Cell Biochem; 2007 Oct; 304(1-2):273-85. PubMed ID: 17636462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J; Lee YJ
    Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts.
    El-Zawahry A; McKillop J; Voelkel-Johnson C
    BMC Cancer; 2005 Jan; 5():2. PubMed ID: 15638938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K; Fang W; Chen Y; Lin S; Chen X
    Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells.
    Perego P; Ciusani E; Gatti L; Carenini N; Corna E; Zunino F
    Biochem Pharmacol; 2006 Mar; 71(6):791-8. PubMed ID: 16438941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells.
    Plante MK; Arscott WT; Folsom JB; Tighe SW; Dempsey RJ; Wesley UV
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):16-22. PubMed ID: 22986577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation.
    Gill C; Dowling C; O'Neill AJ; Watson RW
    Mol Cancer; 2009 Jun; 8():39. PubMed ID: 19549337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
    Szliszka E; Helewski KJ; Mizgala E; Krol W
    Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.
    Fujiwara J; Sowa Y; Horinaka M; Koyama M; Wakada M; Miki T; Sakai T
    Int J Oncol; 2012 May; 40(5):1483-91. PubMed ID: 22328338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
    Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
    Lee YJ; Seol JW; Jeong JK; Moon MH; Park SY
    Mol Med Rep; 2011; 4(6):1255-9. PubMed ID: 21850375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.